Stockscreener 앱 받기
5.72
2.89%
-0.17
시간 외 거래:
5.70
-0.02
-0.35%
전일 마감가:
$5.89
열려 있는:
$5.84
하루 거래량:
3.87M
Relative Volume:
1.25
시가총액:
$1.35B
수익:
$159.11M
순이익/손실:
$-65.81M
주가수익비율:
-47.67
EPS:
-0.12
순현금흐름:
$-81.12M
1주 성능:
-4.83%
1개월 성능:
-16.13%
6개월 성능:
-34.40%
1년 성능:
+42.29%
1일 변동 폭
$5.65
$5.90
1주일 범위
$5.65
$6.44
52주 변동 폭
$3.43
$10.13
Ardelyx Inc Stock (ARDX) Company Profile
명칭
Ardelyx Inc
전화
510-745-7047
주소
34175 ARDENWOOD BLVD., FREMONT, CA
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 개시 | Leerink Partners | Outperform |
| 2023-12-18 | 개시 | Raymond James | Strong Buy |
| 2023-09-07 | 개시 | H.C. Wainwright | Buy |
| 2023-08-25 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-11-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-07-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-03-23 | 개시 | Wedbush | Outperform |
| 2021-01-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 재개 | Citigroup | Buy |
| 2020-02-18 | 재개 | Jefferies | Buy |
| 2020-02-12 | 개시 | Citigroup | Buy |
| 2020-02-10 | 개시 | Cowen | Outperform |
| 2019-04-08 | 개시 | Piper Jaffray | Overweight |
| 2018-08-24 | 개시 | Jefferies | Buy |
| 2018-03-19 | 재개 | Leerink Partners | Outperform |
| 2017-11-29 | 재확인 | Citigroup | Buy |
| 2017-11-22 | 재확인 | Ladenburg Thalmann | Buy |
| 2017-10-17 | 재개 | Leerink Partners | Outperform |
| 2016-03-31 | 개시 | Ladenburg Thalmann | Buy |
| 2016-03-09 | 개시 | Cantor Fitzgerald | Buy |
| 2016-03-03 | 개시 | Citigroup | Buy |
모두보기
Ardelyx Inc 주식(ARDX)의 최신 뉴스
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference - ForexTV.com
What is Wedbush’s Forecast for Ardelyx FY2026 Earnings? - Defense World
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Inve - GuruFocus.com
Citigroup Has Lowered Expectations for Ardelyx (NASDAQ:ARDX) Stock Price - MarketBeat
Wedbush Research Analysts Cut Earnings Estimates for Ardelyx - MarketBeat
Ardelyx, Inc. (NASDAQ:ARDX) Q3 2024 Earnings Call Transcript - MSN
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Simply Wall St
Ardelyx (NASDAQ:ARDX) Stock Price Up 7.3% – Here’s Why - Defense World
Allspring Global Investments Holdings LLC Sells 19,212 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seekin - GuruFocus.com
Ardelyx Third Quarter 2024 Earnings: US$0.003 loss per share (vs US$0.03 profit in 3Q 2023) - Yahoo Finance
Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key Metrics - MSN
Ardelyx (NASDAQ:ARDX) Earns "Buy" Rating from HC Wainwright - MarketBeat
Earnings call: Ardelyx reports solid growth amid Medicare challenges - Investing.com
Earnings call: Ardelyx reports solid growth amid Medicare challenges By Investing.com - Investing.com Canada
Ardelyx (NASDAQ:ARDX) Shares Up 7.3%Should You Buy? - MarketBeat
Ardelyx Target of Unusually High Options Trading (NASDAQ:ARDX) - MarketBeat
Ardelyx CEO Michael Raab sells $147,740 in stock By Investing.com - Investing.com Australia
Ardelyx Inc (ARDX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amidst ... - Yahoo Finance
Ardelyx CEO Michael Raab sells $147,740 in company stock By Investing.com - Investing.com Canada
Ardelyx Reports Robust Q3 2024 Revenue Growth - TipRanks
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update - ForexTV.com
Ardelyx reports Q3 EPS 0c, consensus (5c) - TipRanks
Ardelyx Beats Q3 Sales Estimates, Shares Climb - MSN
Ardelyx: Q3 Earnings Snapshot - Houston Chronicle
ARDXArdelyx, Inc. Latest Stock News & Market Updates - StockTitan
Ardelyx (ARDX) Reports Break-Even Earnings for Q3 - Yahoo Finance
Ardelyx options imply 14.6% move in share price post-earnings - TipRanks
Ardelyx, Inc. Sued for Securities Law ViolationsInvestors Sho - GuruFocus.com
Ardelyx CEO Michael Raab sells $147,740 in stock - Investing.com India
Ardelyx CEO Michael Raab sells $147,740 in company stock - Investing.com
Michael Raab Sells 25,000 Shares of Ardelyx, Inc. (NASDAQ:ARDX) Stock - MarketBeat
ARDX LAWSUIT ALERT: The Gross Law Firm Notifies Ardelyx, Inc. In - GuruFocus.com
Ardelyx's Earnings Outlook - Benzinga
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting - ForexTV.com
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American - The Bakersfield Californian
(ARDX) Trading Report - Stock Traders Daily
Ardelyx reports positive XPHOZAH trial results at ASN Kidney Week - Investing.com India
Ardelyx announces presentation of Xphozah data at Kidney Week - TipRanks
Ardelyx reports positive XPHOZAH trial results at ASN Kidney Week By Investing.com - Investing.com South Africa
Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week - StockTitan
Earnings Preview: Ardelyx (ARDX) Q3 Earnings Expected to Decline - Yahoo Finance
Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business - Simply Wall St
Ardelyx (ARDX) Set to Announce Earnings on Thursday - MarketBeat
Ardelyx, Inc. (ARDX) Stock Price & Chart | Trade Now - Capital.com
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community - ForexTV.com
Ardelyx launches podcast for IBS-C community - Investing.com India
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of ... - The Bakersfield Californian
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Ardelyx Inc (ARDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.47%
자본화:
|
볼륨(24시간):